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Anesthetic bindingCys-loop receptors are pentameric ligand-gated ion channels (pLGICs) mediating fast neurotransmission in the
central and peripheral nervous systems. They are important targets for many currently used clinical drugs,
such as general anesthetics, and for allosteric modulators with potential therapeutic applications. Here, we pro-
vide an overview of advances in the use of solution NMR in structural and dynamic characterization of ion chan-
nels, particularly human Cys-loop receptors. We present challenges to overcome and realistic solutions for
achieving high-resolution structural information for this family of receptors. We discuss how subtle structural
differences among homologous channels deﬁne unique channel pharmacological properties and advocate the
necessity to determine high-resolution structures for individual receptor subtypes. Finally, we describe drug
binding to the TMDs of Cys-loop receptors identiﬁed by solution NMR and the associated dynamics changes rel-
evant to channel functions. This article is part of a Special Issue entitled: NMRSpectroscopy for Atomistic Views of
Biomembranes and Cell Surfaces. Guest Editors: Lynette Cegelski and David P. Weliky.
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Cys-loop receptors, named after the signature 13-residue loop formed
between two conserved cysteine residues, are membrane-spanning ion
channels thatmediate fast neurotransmission in the central andperipher-
al nervous systems. This family of receptors includes the nicotinic acetyl-
choline receptors (nAChRs) and serotonin type-3 receptors (5-HT3Rs)
that conduct cations andmediate excitatory neurotransmission. It also in-
cludes gamma-aminobutyric acid type-A and type-C receptors (GABAARs
andGABACRs) and glycine receptors (GlyRs) that conduct anions andme-
diate inhibitory neurotransmission. Malfunction of these receptors is
308 D.D. Mowrey et al. / Biochimica et Biophysica Acta 1848 (2015) 307–314often associatedwith various neurological disorders, such as epilepsy, de-
pression, cognitive impairment, nicotine and alcohol addiction, congenital
myasthenic syndromes, and startle disease [1–3]. Cys-loop receptors are
important targets for many currently used clinical drugs, such as general
anesthetics, and for potential therapeutics.
Cys-loop receptors are pentameric ligand-gated ion channels
(pLGICs) comprised of ﬁve identical or homologous subunits arranged
around a central channel axis (Fig. 1). Each subunit consists of a
neurotransmitter-binding extracellular domain (ECD), a pore-forming
transmembrane domain (TMD) containing four transmembrane helices
(TM1–TM4), and a large intracellular domain (ICD) connecting TM3 and
TM4 [4]. The ICD has been implicated in receptor assembly, trafﬁcking,
and localization [5–8]. Itmay inﬂuence channel conductance anddesen-
sitization [9–11], but replacing the Cys-loop receptor ICD with a short
TM3–TM4 linker still produced functional channels [12,13]. Neurotrans-
mitter binding to the orthosteric site in the ECD triggers channel open-
ing and allows ions to pass through the cell membrane. Channel activity
can also be modulated allosterically by a variety of ligands bound to
other regions of these receptors. There is emerging interest in the
development of Cys-loop receptor modulators for treating various neu-
rological disorders [14–18].
Given their biological and pharmacological importance, it is highly
desirable to gain a better understanding of Cys-loop receptors' struc-
tures and functions. Four sources of information have contributed to
the overall structural understanding of these receptors. The ﬁrst source
consists of crystallographic studies of ECDs, including acetylcholine
binding proteins (AChBPs) [19–24], the mouse α1-nAChR ECD [25],
and an α7nAChR–AChBP chimera [26]. These structures provide valu-
able information about ligand binding and the resulting conformational
changes in the ECD. The second source includes crystal structures of
prokaryotic homologs of Cys-loop receptors from Erwinia chrysanthemi
(ELIC) in the absence and presence of ligands [27–29], Gloebacter
violaceus (GLIC) in an open or closed conformation [30–32], and eukary-
otic Caenorhabditis elegans glutamate-gated chloride channel α (GluCl)
[33]. The prokaryotic homologs do not contain an ICD and have less than
35% sequence homology with Cys-loop receptors, but share a similar
structural scaffold to the ECD and TMD of Cys-loop receptors. The
third source of structural information for Cys-loop receptors resultsFig. 1. Topology of the Cys-loop receptor. (a) Top viewof a Cys-loop receptor showing the quate
Cys-loop receptor highlighting three domains: ECD (yellow), TMD (green) and ICD (pink). (c) S
The EM structure of the Torpedo marmorata nAChR (PDB ID: 2BG9) was used as the model Cysfrom EM data derived from the Torpedo marmorata nAChR, which
provided a valuable structural model at 4-Å resolution on an intact
nAChR, but little structural information for the ICD [4], probably due
to an intrinsically unstructured nature of the ICD. To date neither EM
nor crystallography has been able to provide high-resolution structures
for human Cys-loop receptors, even though encouraging results in pro-
tein expression and puriﬁcation have been reported for some Cys-loop
receptors in recent years [34–37]. Finally, NMR has provided high-
resolution structures for the TMDs of human α1-GlyR [38], α4β2-
nAChR [39], and α7-nAChR [40]. Moreover, NMR has provided insights
into drug binding and drug-mediated changes in channel dynamics [16,
17,40–43]. There is no doubt that NMRhas established an important po-
sition in structure and dynamics determination of Cys-loop receptors
and other channel proteins.
In this review, we provide an overview of advances in the use of so-
lution NMR in structural and dynamic characterization of ion channels,
particularly human Cys-loop receptors. We discuss challenges and real-
istic solutions for achieving high-resolution structural information for
this family of receptors. We also describe drug binding onto the
Cys-loop receptors' TMD, which is a known target for many Cys-loop
receptor modulators.
2. Current frontier of solution NMR for channel proteins
In the past decade, NMR has emerged as a powerful tool in investi-
gating structures and dynamics of channel proteins at atomic resolution
[44,45]. Although X-ray crystallography has been successfully used to
solve numerous channel structures, many systems have not been
crystallized or well diffracted even after persistent efforts. Since each
channel protein can sample multiple conformations, some discrepan-
cies reﬂected in NMR and crystal structures from the same protein
may be valuable for understanding channel plasticity. Furthermore,
NMR can effectively characterize channel motions, in the absence and
presence of drug modulation, which are relevant to channel functions.
Altogether, NMR is highly valuable and complementary to other tools
in providing structural and functional information for channels. This
review will focus only on solution NMR's applications to channel pro-
teins (Table 1), particularly to Cys-loop receptors.rnary arrangement of theﬁve subunits around the central channel axis. (b) Side viewof the
ide view of a single subunit showing the labels for four transmembrane helices, TM1–TM4.
-loop receptor [4].
Table 1
Summary of structures for channels and representative integral membrane proteins determined by solution NMR.
Structural Motif Protein Oligomerization state MW (kDa) PDB ID Membrane mimetic Reference
β-Barrel OmpX ● 16.4 1Q95 DHPC [48]
OmpA ● 19.1 1G90 DPC [49]
PagP ● 20.2 1MM4 DPC [125]
VDAC-1 ● 31.9 2K4T LDAO [46]
OmpG ● 32.8 2JQY DPC [47]
α-Helix KvaP ●●
●●
16.2 2KYH D7PC [126]
M2 ●●
●●
20.8 2RLF DHPC [50]
PLN ●●●●● 30.5 2KYV DPC [61]a
p7 ●●●
●●●
40.6 2M6X DPC [63]
KcsA ●●
●●
71.2 2A9H DPC [103]
α7-nAChR ●●●●● 73.0 2MAW LDAO [40]
α4-nAChR ●●●●● 75.0 2LLY LDAO [39]
β2-nAChR ●●●●● 75.4 2LM2 LDAO [39]
α1-GlyR ●●●●● 86.5 2M6B LPPG [38]
α-Helix (non-channel) SRII ● 26.7 2KSY DHPC [65]
PR ● 27.0 2L6X D7PC [127]
DAGK ●●● 39.4 2KDC DPC [64]
a Structure determined by hybrid solution and solid-state NMR methods.
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dispersion thanα helical proteins. Solution NMR structures for β-barrel
channels, including bacterial outer membrane proteins and the voltage
dependent anion channel from human mitochondria (VDAC-1), were
determined in micelles with protein molecular weights in a range of
16–33 kDa [46–49]. Progress has also been made over the last decade
in solution NMR structural determination of α-helical channels.
Intensive structural and functional characterization was conducted on
the homo-tetrameric proton channels (M2 channels) of inﬂuenza A
and inﬂuenza B in DHPC micelles, yielding NMR structures for AM2
(~21 kDa) and the BM2 transmembrane (~15 kDa) and cytoplasmic
(~41 kDa) domains in different functional states [50,51]. However,
some structural differences ofM2derived from solid stateNMRwere re-
ported [52,53]. As a proof of principle, the NMR structure of a “soluble”
version of the 46-kDa homo-tetrameric KcsA [54] was determined and
proven to agree well with the KcsA crystal structure [55]. The structure
of the monomeric subunit of KcsA was also probed in SDSmicelles [51].
With the use of solution NMR, several studies revealed K+ and pH-
dependent conformational and dynamics changes of KcsA [56–60].
The structural dynamics and topologyof thehomopentameric phospho-
lamban (PLN) channel (~31 kDa)were determined using a combination
of solution and solid-state NMRmethods to reveal the role of PLN in the
regulation of calcium transport [61,62].More recently, an unusual archi-
tecture of the 42-kDa homo-hexameric p7 channel, the hepatitis C virus
viroporin, was revealed using the latest solution NMR technologies [63].
It is also noteworthy that structures of several relatively large non-
channel multi-span transmembrane proteins have been determined in
micelles using solution NMR, including the 40-kDa homotrimer DAGK
[64] and the seven-helix TM receptor sensory rhodopsin II (~27 kDa)
[65]. The reported structures for channels and non-channel transmem-
brane proteins highlight the advances made in using solution NMR for
tackling atomic insights into complex proteins. Ironically, they also
mark the current upward limit of protein molecular weights amenable
for high-resolution NMR structural studies.
3. Use of NMR for structures and dynamics of Cys-loop receptors
3.1. Challenges and solutions for NMR studies of Cys-loop receptors
A full-length Cys-loop receptor has a typical molecular weight of
~250 kDa, which is too large for structure determination using solution
NMR. However, individual domains of Cys-loop receptors can bestudied separately after proper truncation. This is particularly true for
the TMD, which spontaneously assembles into pentameric channels in
membrane mimetics. Moreover, one can evaluate whether a TMD
channel retains functional and pharmacological characteristics of the
authentic Cys-loop receptor before investing effort into structure
determination.
3.1.1. Spontaneous pentameric assembly
Electronmicroscopy images [38] and size exclusion chromatography–
multi-angle light scattering (SEC–MALS) [39,40] revealed a spontane-
ous pentameric assembly of the Cys-loop receptor TMD in micelles.
The ability to form channel assemblies was observed even for the
isolated pore-lining TM2 helix of the GlyR [66], GABAA receptor [67],
and nAChR [68,69]. In contrast, quaternary structural assembly of an
isolated ECD is less certain. The isolated ECD of GLIC presents as a
hexamer in crystal structure [70] or monomer in solution NMR [71],
even though its tertiary structure remains the same as that observed
in the pentameric structure of the full-length GLIC [30,31]. Varying olig-
omerization states were also observed for the ECD α1-GlyR subunit
[72]. The preservation of the native quaternary assembly for an isolated
TMD and the destruction observed for the ECD alone suggests that the
TMD drives the pentameric assembly of Cys-loop receptors.
3.1.2. Validation of channel functions
It is vital to assure that the channels used for structural studies are
functional and retain essential pharmacological characteristics of
Cys-loop receptors. Several approaches have been used for functional
assessments. First, theNMRmagnetization-inversion-transfer (MIT) ex-
periment [73,74] is convenient for tracking ion permeation through
channels. It has been used to characterize Cl− transport through the
human α1-GlyR TMD channel reconstituted in vesicles. The MIT exper-
iment demonstrates that the channel conductance could be inhibited by
the pore-blocker picrotoxin, a signature for the native pore struc-
ture [38]. Second, for Na+-conducting channels, such as α4β2- and
α7-nAChRs, the Na+ ﬂux assay is useful to quickly assess whether the
TMD channels are functional [39]. Finally, injection of the α7-nAChR
TMD, puriﬁed in LDAO micelles, into Xenopus laevis oocytes has yielded
functional channels that retain pharmacological features of the native
α7-nAChR [40].
These measurements served not only for the validation of functional
structures, but also for the revelation of the interplay between Cys-loop
receptor domains. The channels have a much higher opening
310 D.D. Mowrey et al. / Biochimica et Biophysica Acta 1848 (2015) 307–314probability in the absence of the ECD than in the intact Cys-loop recep-
tors, where the channels are closed until agonist binds to the ECD
[75–79]. Based on this observation, we hypothesize that the ECD sets
restraints on the intrinsically opened TMD; agonist binding to the ECD
relieves the restraints temporarily so that the TMD can rapidly “relax”
into its preferred open conformation before transitioning into
desensitized conformations.3.1.3. Optimization of NMR spectra
For a chosen channel protein, the sample preparation and NMR ex-
perimental conditions should be optimized in order to obtain adequate
quality spectra for structural studies. In particular, one needs to ﬁne-
tune protein stability. When ECD or TMD is isolated, the hydrophobic
residues at the ECD–TMD interface, protected originally by Van der
Waals contacts, becomeexposed towater and cause protein destabiliza-
tion. Substituting two or three non-polar residues in the TM2–TM3 link-
er with hydrophilic residues, as shown in Fig. 2, greatly prevented
aggregation of the α4β2- and α7-nAChR TMDs [39,40]. Mutations of
charged residues at the N- and C-termini were also beneﬁcial for
preventing aggregation of the nAChR TMDs at a relatively low pH suit-
able for NMRdata collection [39,40], but suchmutationswere foundun-
necessary for the α1-GlyR TMD [38]. In each case the large ICD was
replaced with a glycine linker to limit the molecular size and number
of peaks in the spectra. While the ICD plays roles in receptor assembly
and trafﬁcking, fully functional receptors could be obtained by replacing
the Cys-loop receptor ICD with the short TM3–TM4 linker observed in
GLIC [12,13].
Selecting a proper membrane mimetic is another important step for
sustaining stable channel folding for the purpose of acquiring good
quality NMR spectra. A large number of membrane mimetic options
for solution NMR studies of membrane proteins are available [80–82].
Although bicelles have been used in studies of transmembrane proteins
[83,84], micelles remain a primary choice for solution NMR. The ability
of micelles to sustain stability and functions of membrane proteins has
been documented [85]. A speciﬁc choice of detergent needs to be tested
for each channel protein. For example, LDAO is a good choice for the
α4β2- and α7-nAChR TMDs [39,40], while LPPG is better for the
α1-GlyR TMD [38]. A molar ratio of detergent to protein concentrations
between 150 and 250 is optimal to maintain protein stability and to
achieve high quality NMR spectra [38–40].
TROSY-based [86] triple-resonance experiments and TROSY-based
NOESY experiments are well suited for the Cys-loop TMD, which typi-
cally has ~120 residues. For homo-pentamers, such as the α7-nAChRSNARRLPLFYTINLIIPCLLISCLTVLVFYLPSE
SNAEELPLFYTINLIIPCLLISCLTVLVFYLPSE
SNARRKPLFYTINLIIPCVLITSLAILVFYLPSD
SNAEEEPLFYTINLIIPCVLITSLAILVFYLPSD
SNARR-TLYYGLNLLIPCVLISALALLVFLLPAD
SNAEE-ELYYGLNLLIPCVLISALALLVFLLPAD
IGEYLLFTMIFVTLSIVITVFVLNVHHRSPRTHT
IGEYLLFTMIFVTLSIVITVFVLNVHHRSPETHT
VGKYLMFTMVLVTFSIVTSVCVLNVHHRSPTTHT
VGEYLMFTMVLVTFSIVTSVCVLNVHHRSPETHT
IAQYFASTMIIVGLSVVVTVIVLQYHHHDPDGGK
IAQYFASTMIIVGLSVVVTVIVLQYHHHDPDGGE
β2 
β2’ 
β2 
β2’ 
α7
α7’
α7
α7’
.....210.......220.......230.....
......280.......290.......300....
α4
α4’
α4
α4’
TM1
TM3
.
.
Fig. 2. Sequence comparison for α4-, β2-, and α7-nAChRs and their respective NMR construct
mental condition. Glutamate mutations (red) at the N- and C-termini lower the isoelectric poin
TM2–TM3 linker increase sample stability in the absence of the ECD. The sequence numberingand α1-GlyR TMD [38,40], the NMR spectra can beneﬁt greatly from
magnetic symmetry, in which ﬁve identical polypeptides assemble a
channel. For hetero-pentamers, such as the α4β2-nAChR, the isotope
labeled α4 subunit was mixed with the unlabeled β2 or vice versa to
avoid spectral crowding [39]. Selective labeling is often needed to re-
solve ambiguities of chemical shift assignments [38]. In addition to
chemical shift index [87,88] and nuclear Overhauser effects (NOEs)
[89–92], long-range spatial restraints from paramagnetic relaxation en-
hancement (PRE) [93], and orientation restraints from residual dipole
couplings (RDCs) [83,94] also aided in determination of the structures
of the TMDs [38–40].3.2. NMR structures of Cys-loop receptors
NMR structures for the full-length TMD of the humanα1-GlyR (PDB
ID: 2M6I; 2M6B) [38], human α7- (PDB ID: 2MAW) [40], α4- (PDB ID:
2LLY), and β2-nAChRs (PDB ID: 2LM2; 2KSR) [39,40,95] represent the
ﬁrst few atomic resolution experimental TMD structures of mammalian
Cys-loop receptors. Although a four-α-helical-bundle scaffold is com-
mon to TMDs of all Cys-loop receptors, NMR structures reveal atomic
details unique to individual channels that can account for their distinct
functional and pharmacological properties.
Take the human α1-GlyR as an example. Several structural and dy-
namic features of the open-channel α1-GlyR structures revealed by
NMR [38] could not be observed via homology modeling [96,97]. The
pore-lining TM2 of α1GlyR has a shorter helix (Fig. 3). It is more than
two helical turns (9 residues) shorter than TM2 shown in the cryo-EM
structure of nAChR [4], and six residues shorter than observed in the
NMR structures of α4β2- and α7-nAChRs [39,40], and seven residues
shorter than in crystal structures of ELIC [27,28], GLIC [30,31,98] and
GluCl [33]. Moreover, the C-terminal end of the α1-GlyR TM2 shows
two conformations inNMR spectra and displays conformationalﬂexibil-
ity that is likely related to channel functions [99,100]. A kink at A288
changes the α1-GlyR TM3 helix axis direction by ∼33° (Fig. 3). Such a
kink has not been observed in structures for nAChRs or other homolo-
gous pLGICs [4,27,28,30,31,33,39,40,98]. The shorter TM2 helix with a
ﬂexible C-terminal end and the TM3 helical kink are intrinsic to the
α1-GlyR. These structural features were observed in the studies of the
α1-GlyR TMD using different membrane mimetics and varying num-
bers of TMD helices [38,66,83,101,102].
High-resolution NMR structures for human neuronal nAChRs
provide insights into unique characteristics of individual subunits.
While theNMRstructures forα7-,α4-, andβ2-nAChRs share a commonCGEKITLCISVLLSLTVFLLLITEIIPSTSLVIPL
CGEKITLCISVLLSLTVFLLLITEIIPSTSSVSPS
CGEKMTLCISVLLALTVFLLLISKIVPPTSLDVPL
CGEKMTLCISVLLALTVFLLLISKIVPPTSSDSPS
SGEKISLGITVLLSLTVFMLLVAEIMPATSDSVPL
SGEKISLGITVLLSLTVFMLLVAEIMPSTSDSSPS
-----IDRIFLWMFIIVCLLGTVGLFLPPWLAG-
GGGGGIDRIFLWMFIIVCLLGTVGLFLPPWLAGE
-----IDRLFLWIFVFVCVFGTIGMFLQPLFQN-
GGGGGIDRLFLWIFVFVCVFGTIGMFLQPLFQEE
-----VDRLCLMAFSVFTIICTIGILMSAPNFV--
GGGEGIDRLCLMAFSVFTIICTIGILMSAPNFVEE
..240.......250.......260.......270
........450.......460.......470....
TM2
TM4
s, α4′, β2′, and α7′. A few point mutations stabilized the channels under the NMR experi-
t and prevent protein precipitation at pH 4.7. Serine mutations (green) introduced to the
corresponds to that of the α7-nAChR.
Fig. 3. Structural comparison of Cys-loop receptor TMDs. Representative solutionNMR structures for (a) theα1-GlyR TMD (PDB ID: 2M6I); (b) theα4- (PDB ID: 2LLY) and (c)β2- (PDB ID:
2LM2) nAChRs; and (d) the cryo-EM structure of the Torpedo marmorata nAChR (PDB ID: 2BG9) with the α1 subunit highlighted. In each colored subunit, the TM2 and TM3 helices are
labeled 2 and 3, respectively. Note a shorter length of the TM2 helix in α1-GlyR (a) than those in nAChRs (b–d). Also note the unique helical kink in the α1-GlyR TM3 that is absent in
nAChRs.
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among the nAChR subtypes exist. Such differences can affect intra-
subunit cavities, both in size and shape, and ultimately affect drug bind-
ing. The α7- andα7β2-nAChRs are a good pair of Cys-loop receptors to
underscore the importance of structural individuality in shaping the
unique pharmacology for each Cys-loop receptor subtype [42]. Even
though theα7 and β2 TMDs are ~50% identical in sequence, a variation
in cavity-lining residues and a less than 10° orientation difference of
TM2 helix yield disparity for the cavity at the EC end of the TMD:
~180 Å3 and ~120 Å3 for β2 and α7, respectively. Unlike the cavity in
β2, a smaller cavity in α7 excludes the anesthetic isoﬂurane from
binding. The structural insights offer an explanation as to why α7 is
functionally insensitive to isoﬂurane while α7β2 is hypersensitive
[42]. The subtle structural differences, such as those reﬂected in α7
and β2, are often diminished in homologymodeling. Thus, comprehen-
sive structure determination for individual subunits is necessary in
order to design therapeutics targeting speciﬁc subtypes of Cys-loop
receptors.
Chemical shift perturbation experiments identiﬁed interacting
residues between the α4 and β2 subunits in the heteromeric α4β2-
nAChR [39]. Such information was used to generate a pentameric
assembly for the α4β2 TMD. We notice that leucine–leucine and
leucine–isoleucine inter-subunit contacts make up 31% and 39% of the
total inter-subunit contacts, respectively. They are the predominant
driving force for the pentameric assembly of theα4β2 channel. In addi-
tion, other hydrophobic contacts involving valine or methionine make
up 22% of the inter-subunit contacts. The role of leucine zippers in
folding and/or oligomerization of other membrane-spanning proteins
has been well documented [103,104]. The importance of a leucine–
isoleucine zipper, interlocking of alternating leucine and isoleucine res-
idues between subunits, has also been demonstrated in structures of
PLN [61].
Rich leucine–leucine and leucine–isoleucine contacts between
subunits are associated with the abundance of leucine and isoleucineFig. 4. Drug binding sites in the human α1-GlyR and α4β2-nAChR TMDs. (a) Left: top view of t
each subunit; right: side view of the cannabinoid binding site in anα1-GlyR subunit, which invo
halothanebinding sites in theα4β2-nAChR TMD. Theα4 (PDB ID: 2LLY) andβ2 (PDB ID: 2LM2)
intra-subunit sites (yellow-green) and inter-subunit sites (cyan) between α4 and β2 subunits
intra-subunit sites were observed at the IC end of the TMD for both α4 and β2. Note that the iresidues that constitute ~30% of the residues in the α4β2-nAChR
TMD. In contrast, α1-GlyR has ~10% less leucine and isoleucine in its
TMD. Thereby, only ~10% and ~5% inter-subunit leucine–leucine and
leucine–isoleucine contacts are observed in the α1-GlyR structure [38].
Aromatics, however, play a more signiﬁcant role in assembly of theα1-
GlyR channel [38] than that of the α4β2-nAChR channel, where only
one pair of aromatic contacts between α4 and β2 subunits was found
[39].
4. Cys-loop receptor TMDs as drug targets
The TMDs of Cys-loop receptors are targets of general anesthetics
[41,42,105–112], neurosteroids [113,114], and various positive alloste-
ric modulators (PAMs) and negative allosteric modulators (NAMs) of
therapeutic potential [11,18,43,115]. Complementary to photoafﬁnity
labeling [105–112,116] and crystallography [29,48,98,117] used for
identifying drug binding sites in Cys-loop receptors and homologous
pLGICs, solution NMR is another effective tool for providing atomic de-
tails of drug binding sites [16,17,40–42]. Furthermore, solutionNMR can
identify drug-induced changes in protein dynamics [118–120] and pro-
vide insight into potential functional consequences due to drug binding
[16,17,42].
A novel binding site for cannabinoids was identiﬁed in human GlyRs
(Fig. 4a) by using solution NMR titration and NOESY experiments,
which demonstrated a direct contact between cannabinoids and the
residue S296 in α1-GlyR [16] or in α3-GlyR [17]. In addition, the NMR
experiments revealed two coexisting states of binding on a relatively
slow exchange timescale or cannabinoid-induced conformation ex-
change at S296 [17]. When the binding information is mapped onto
the NMR structure of the α1-GlyR channel [38], it becomes clear that
S296 exposes to lipids and the cannabinoid-binding pocket is involved
with both TM3 of GlyR and surrounding lipids. The atomic insight re-
vealed by NMR adds a valuable structural basis in pursuing glycinergic
cannabinoids for chronic pain treatment [16,17]. The cannabinoid-he GlyR-α1 TMD (PDB ID: 2M6I) highlighting a novel cannabinoid binding site (green) in
lves residue S296 (green) in TM3 and the adjacent lipids (yellow) [16]. (b) NMR-identiﬁed
subunits are shown inpink andgray, respectively. Halothanebindingwas observed at both
. Inter-subunit halothane sites were observed exclusively at the EC end of the TMD, while
ntra-subunit site at the EC end of the TMD was unique to β2.
Fig. 5.Dynamics as a critical link between drug binding and changes in channel function. (a) NMR structures of β2- (top) andα7- (bottom) nAChRs show different sizes of cavities (trans-
parent surface) at the EC end of their respective TMDs. The anesthetic isoﬂurane (green surface) binds to this cavity inβ2, but to a different site inα7. The cavity-lining residue 22′ is shown
as blue and red sticks for β2 andα7, respectively. (b) NMR spectra for residue 22′ of β2 (top) andα7 (bottom) in the presence of 0mM (black), ~1.5 mM (cyan), and ~3.0 mM (magenta)
isoﬂurane. Note that only in β2 was isoﬂurane-induced peak splitting observed, indicating a dynamics change for the 22′ residue on the μs time-scale. In contrast, the isoﬂurane-induced
peak splittingwas not observed inα7. (c) Isoﬂurane (Iso) can inhibit the current elicited by acetylcholine (ACh) inXenopus laevis oocytes expressingα7β2 (top), but cannot affect currents
in the case of α7 (bottom). The α7β2-V22′M (top) and α7-M22′V (bottom) mutants have reversed functional responses to isoﬂurane in comparison to their parent channels. The func-
tional sensitivity to isoﬂurane (c) is correlated to the dynamics modulation by isoﬂurane (b) on these channels. The currents were recorded by two-electrode voltage clamp held at
−60 mV. The vertical and horizontal scales represent 25 nA and 1 min, respectively.
312 D.D. Mowrey et al. / Biochimica et Biophysica Acta 1848 (2015) 307–314binding pocket found in humanα1- orα3-GlyRs also highlights the ap-
propriateness of shallow and lipid-facing pockets for drug binding to
Cys-loop receptors.
Most drug-binding pockets found in the TMDs of Cys-loop receptors
and the homologous pLGICs were found more deeply embedded into
the proteins. For low afﬁnity drugs, such as volatile general anesthetics,
multiple binding sites often exist in one channel. For example, the anes-
thetic halothane binds to both intra- and inter-subunit sites in the
α4β2-nAChR TMD (Fig. 4b). Similar binding sites were also found sepa-
rately in the muscle type nAChR with the photo-labeled halothane
[112], the ﬂuorescence quenching of GLIC by halothane [121], crystal
structures of GLIC bound with the anesthetics desﬂurane or propofol
[117], crystal structures of the GLIC F14′A mutant bound with alcohols
[48], and the crystal structure of ELIC boundwith a derivative of chloro-
form [29]. The binding at both intra- and inter-subunit sites inhibited
these cation-conducting channels except the GLIC F14′A mutant, in
which ethanol binding to an inter-subunit site caused potentiation of
the channel current [48]. Thus, the relation between binding sites and
functional impact varies among individual channels. The binding to an
inter-subunit site can potentiate function in one channel, but inhibit
function of another.
Channel function is closely associatedwith channel motion. The drug
binding relevant to a channel's functional impact is often associatedwith
the drug-induced changes in channel dynamics that can be observed in
NMR spectra. Take the recent study on the α7- and α7β2-nAChRs as
an example (Fig. 5). The α7-nAChR is functionally insensitive to volatile
anesthetics [122,123], such as isoﬂurane. The presence of β2 makes the
α7β2-nAChR hypersensitive to isoﬂurane [42]. We identiﬁed different
isoﬂurane binding sites in α7 and β2 by using NMR experiments [42].
More importantly, we observed that isoﬂurane induced a transition of
several β2 residues from a single peak to double peaks in NMR spectra,
which suggested a shift in the motional timescale or conformational
equilibrium [124]. Such transitions were observed for both the V22′
residue lining the isoﬂurane-binding-site and the channel gate residue
L9′ in β2. In contrast, similar dynamics changes were not detected in
α7. Only isoﬂurane binding to the β2-speciﬁc site could affect the chan-
nel dynamics and produce a functional consequence.5. Closing remarks
There are many subtypes of Cys-loop receptors covering a wide
range of functions and pharmacology. It remains a great challenge to
determine atomic-resolution structures of these receptors. Recent tech-
nological advances in NMR, crystallography, and cryo-EM have rapidly
improved our ability to study complex channel proteins. Integrated
information generated by these tools will further accelerate our under-
standing of Cys-loop receptors. Solution NMR will continue to provide
atomistic insights into channel structures and dynamics, drug binding
(especially at low afﬁnities), and allosteric modulation.
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